nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ATP4A—hematologic cancer	0.254	0.693	CbGaD
Pantoprazole—ABCG2—hematologic cancer	0.0795	0.217	CbGaD
Pantoprazole—ABCB1—hematologic cancer	0.0331	0.0903	CbGaD
Pantoprazole—ABCG2—Clofarabine—hematologic cancer	0.0234	0.0576	CbGbCtD
Pantoprazole—CYP1A2—Anagrelide—hematologic cancer	0.0139	0.0342	CbGbCtD
Pantoprazole—ABCG2—Daunorubicin—hematologic cancer	0.0137	0.0337	CbGbCtD
Pantoprazole—ABCG2—Teniposide—hematologic cancer	0.0119	0.0293	CbGbCtD
Pantoprazole—ABCG2—Cladribine—hematologic cancer	0.0114	0.0281	CbGbCtD
Pantoprazole—ABCG2—Imatinib—hematologic cancer	0.0105	0.0258	CbGbCtD
Pantoprazole—ABCG2—Nilotinib—hematologic cancer	0.00955	0.0235	CbGbCtD
Pantoprazole—CYP2C9—Bexarotene—hematologic cancer	0.0087	0.0214	CbGbCtD
Pantoprazole—ABCG2—Dasatinib—hematologic cancer	0.00844	0.0208	CbGbCtD
Pantoprazole—ABCB1—Lenalidomide—hematologic cancer	0.00844	0.0208	CbGbCtD
Pantoprazole—ABCG2—Mitoxantrone—hematologic cancer	0.00834	0.0205	CbGbCtD
Pantoprazole—SLCO1B1—Irinotecan—hematologic cancer	0.00827	0.0203	CbGbCtD
Pantoprazole—CYP1A2—Carmustine—hematologic cancer	0.00732	0.018	CbGbCtD
Pantoprazole—CYP2C9—Idarubicin—hematologic cancer	0.00721	0.0177	CbGbCtD
Pantoprazole—ABCG2—Irinotecan—hematologic cancer	0.00657	0.0161	CbGbCtD
Pantoprazole—CYP2C19—Bortezomib—hematologic cancer	0.00641	0.0158	CbGbCtD
Pantoprazole—CYP1A2—Methoxsalen—hematologic cancer	0.00622	0.0153	CbGbCtD
Pantoprazole—CYP1A2—Bortezomib—hematologic cancer	0.00592	0.0145	CbGbCtD
Pantoprazole—ABCG2—Vincristine—hematologic cancer	0.00574	0.0141	CbGbCtD
Pantoprazole—CYP1A2—Daunorubicin—hematologic cancer	0.00566	0.0139	CbGbCtD
Pantoprazole—CYP2C19—Thalidomide—hematologic cancer	0.00559	0.0137	CbGbCtD
Pantoprazole—CYP1A2—Alitretinoin—hematologic cancer	0.00554	0.0136	CbGbCtD
Pantoprazole—ABCG2—Cisplatin—hematologic cancer	0.00535	0.0132	CbGbCtD
Pantoprazole—CYP2C9—Bortezomib—hematologic cancer	0.00533	0.0131	CbGbCtD
Pantoprazole—CYP2C19—Teniposide—hematologic cancer	0.00533	0.0131	CbGbCtD
Pantoprazole—ABCG2—Etoposide—hematologic cancer	0.00526	0.0129	CbGbCtD
Pantoprazole—CYP1A2—Thalidomide—hematologic cancer	0.00515	0.0127	CbGbCtD
Pantoprazole—CYP3A4—Bexarotene—hematologic cancer	0.00506	0.0124	CbGbCtD
Pantoprazole—ABCB1—Daunorubicin—hematologic cancer	0.00495	0.0122	CbGbCtD
Pantoprazole—CYP2C19—Ifosfamide—hematologic cancer	0.00492	0.0121	CbGbCtD
Pantoprazole—ABCB1—Alitretinoin—hematologic cancer	0.00485	0.0119	CbGbCtD
Pantoprazole—CYP3A4—Busulfan—hematologic cancer	0.0047	0.0116	CbGbCtD
Pantoprazole—CYP3A4—Lomustine—hematologic cancer	0.0047	0.0116	CbGbCtD
Pantoprazole—CYP2C19—Imatinib—hematologic cancer	0.0047	0.0116	CbGbCtD
Pantoprazole—CYP2C9—Thalidomide—hematologic cancer	0.00464	0.0114	CbGbCtD
Pantoprazole—CYP1A2—Dacarbazine—hematologic cancer	0.00443	0.0109	CbGbCtD
Pantoprazole—CYP2C9—Teniposide—hematologic cancer	0.00443	0.0109	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—hematologic cancer	0.00437	0.0108	CbGbCtD
Pantoprazole—CYP1A2—Imatinib—hematologic cancer	0.00434	0.0107	CbGbCtD
Pantoprazole—ABCG2—Dexamethasone—hematologic cancer	0.00432	0.0106	CbGbCtD
Pantoprazole—CYP3A4—Thiotepa—hematologic cancer	0.00419	0.0103	CbGbCtD
Pantoprazole—CYP2C9—Ifosfamide—hematologic cancer	0.00409	0.0101	CbGbCtD
Pantoprazole—CYP2C9—Imatinib—hematologic cancer	0.00391	0.0096	CbGbCtD
Pantoprazole—ABCB1—Imatinib—hematologic cancer	0.00379	0.00932	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—hematologic cancer	0.00359	0.00882	CbGbCtD
Pantoprazole—CYP2C9—Nilotinib—hematologic cancer	0.00355	0.00873	CbGbCtD
Pantoprazole—CYP1A2—Dasatinib—hematologic cancer	0.00348	0.00856	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—hematologic cancer	0.00348	0.00854	CbGbCtD
Pantoprazole—ABCB1—Nilotinib—hematologic cancer	0.00345	0.00847	CbGbCtD
Pantoprazole—ABCB1—Vinorelbine—hematologic cancer	0.00342	0.0084	CbGbCtD
Pantoprazole—CYP3A4—Methoxsalen—hematologic cancer	0.00326	0.00801	CbGbCtD
Pantoprazole—CYP3A4—Bortezomib—hematologic cancer	0.0031	0.00762	CbGbCtD
Pantoprazole—CYP2C19—Prednisone—hematologic cancer	0.0031	0.00761	CbGbCtD
Pantoprazole—ABCB1—Dasatinib—hematologic cancer	0.00304	0.00749	CbGbCtD
Pantoprazole—ABCB1—Mitoxantrone—hematologic cancer	0.00301	0.00739	CbGbCtD
Pantoprazole—CYP3A4—Daunorubicin—hematologic cancer	0.00297	0.00729	CbGbCtD
Pantoprazole—ABCB1—Betamethasone—hematologic cancer	0.00268	0.00659	CbGbCtD
Pantoprazole—ABCB1—Gemcitabine—hematologic cancer	0.00266	0.00653	CbGbCtD
Pantoprazole—ABCB1—Prednisolone—hematologic cancer	0.00264	0.0065	CbGbCtD
Pantoprazole—CYP3A4—Cytarabine—hematologic cancer	0.00262	0.00643	CbGbCtD
Pantoprazole—CYP3A4—Teniposide—hematologic cancer	0.00258	0.00633	CbGbCtD
Pantoprazole—ABCB1—Prednisone—hematologic cancer	0.0025	0.00614	CbGbCtD
Pantoprazole—CYP3A4—Ifosfamide—hematologic cancer	0.00238	0.00585	CbGbCtD
Pantoprazole—ABCB1—Irinotecan—hematologic cancer	0.00237	0.00582	CbGbCtD
Pantoprazole—CYP3A4—Imatinib—hematologic cancer	0.00227	0.00558	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—hematologic cancer	0.00217	0.00533	CbGbCtD
Pantoprazole—CYP3A4—Ruxolitinib—hematologic cancer	0.00214	0.00526	CbGbCtD
Pantoprazole—ABCB1—Vinblastine—hematologic cancer	0.00211	0.00518	CbGbCtD
Pantoprazole—ABCB1—Vincristine—hematologic cancer	0.00207	0.00509	CbGbCtD
Pantoprazole—CYP3A4—Nilotinib—hematologic cancer	0.00206	0.00507	CbGbCtD
Pantoprazole—CYP3A4—Vinorelbine—hematologic cancer	0.00205	0.00503	CbGbCtD
Pantoprazole—CYP2C9—Cisplatin—hematologic cancer	0.00199	0.00489	CbGbCtD
Pantoprazole—CYP2C19—Dexamethasone—hematologic cancer	0.00193	0.00475	CbGbCtD
Pantoprazole—ABCB1—Cisplatin—hematologic cancer	0.00193	0.00475	CbGbCtD
Pantoprazole—ABCB1—Etoposide—hematologic cancer	0.0019	0.00466	CbGbCtD
Pantoprazole—CYP3A4—Triamcinolone—hematologic cancer	0.00187	0.0046	CbGbCtD
Pantoprazole—CYP3A4—Dasatinib—hematologic cancer	0.00182	0.00448	CbGbCtD
Pantoprazole—CYP3A4—Mitoxantrone—hematologic cancer	0.0018	0.00443	CbGbCtD
Pantoprazole—CYP2C9—Dexamethasone—hematologic cancer	0.00161	0.00395	CbGbCtD
Pantoprazole—CYP3A4—Betamethasone—hematologic cancer	0.00161	0.00395	CbGbCtD
Pantoprazole—CYP3A4—Prednisolone—hematologic cancer	0.00158	0.0039	CbGbCtD
Pantoprazole—ABCB1—Dexamethasone—hematologic cancer	0.00156	0.00383	CbGbCtD
Pantoprazole—CYP3A4—Prednisone—hematologic cancer	0.0015	0.00368	CbGbCtD
Pantoprazole—CYP3A4—Irinotecan—hematologic cancer	0.00142	0.00349	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—hematologic cancer	0.00129	0.00318	CbGbCtD
Pantoprazole—CYP3A4—Vinblastine—hematologic cancer	0.00126	0.0031	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—hematologic cancer	0.00125	0.00308	CbGbCtD
Pantoprazole—CYP3A4—Vincristine—hematologic cancer	0.00124	0.00305	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—hematologic cancer	0.00114	0.00279	CbGbCtD
Pantoprazole—ATP4A—hematopoietic system—hematologic cancer	0.00104	0.151	CbGeAlD
Pantoprazole—CYP3A4—Dexamethasone—hematologic cancer	0.000934	0.0023	CbGbCtD
Pantoprazole—Esomeprazole—ATP4A—hematologic cancer	0.000921	0.253	CrCbGaD
Pantoprazole—CYP3A4—Doxorubicin—hematologic cancer	0.000775	0.00191	CbGbCtD
Pantoprazole—ATP4A—blood—hematologic cancer	0.000688	0.1	CbGeAlD
Pantoprazole—Rabeprazole—ATP4A—hematologic cancer	0.000666	0.183	CrCbGaD
Pantoprazole—ATP4A—testis—hematologic cancer	0.000569	0.0827	CbGeAlD
Pantoprazole—SLCO1B1—hematopoietic system—hematologic cancer	0.000557	0.0809	CbGeAlD
Pantoprazole—Omeprazole—ATP4A—hematologic cancer	0.000543	0.149	CrCbGaD
Pantoprazole—Lansoprazole—ATP4A—hematologic cancer	0.000496	0.136	CrCbGaD
Pantoprazole—SLCO1B1—blood—hematologic cancer	0.000369	0.0536	CbGeAlD
Pantoprazole—CYP2C19—hematopoietic system—hematologic cancer	0.000363	0.0527	CbGeAlD
Pantoprazole—Omeprazole—ABCC3—hematologic cancer	0.00035	0.096	CrCbGaD
Pantoprazole—CYP1A2—hematopoietic system—hematologic cancer	0.000296	0.0431	CbGeAlD
Pantoprazole—CYP2C9—hematopoietic system—hematologic cancer	0.000281	0.0409	CbGeAlD
Pantoprazole—CYP2C19—blood—hematologic cancer	0.00024	0.0349	CbGeAlD
Pantoprazole—CYP3A4—hematopoietic system—hematologic cancer	0.000214	0.0312	CbGeAlD
Pantoprazole—Rabeprazole—ABCG2—hematologic cancer	0.000208	0.0572	CrCbGaD
Pantoprazole—ABCG2—blood—hematologic cancer	0.000204	0.0296	CbGeAlD
Pantoprazole—ABCG2—bone marrow—hematologic cancer	0.000197	0.0287	CbGeAlD
Pantoprazole—CYP1A2—blood—hematologic cancer	0.000196	0.0285	CbGeAlD
Pantoprazole—CYP2C9—blood—hematologic cancer	0.000186	0.0271	CbGeAlD
Pantoprazole—ABCG2—lung—hematologic cancer	0.000179	0.026	CbGeAlD
Pantoprazole—CYP1A2—lung—hematologic cancer	0.000172	0.025	CbGeAlD
Pantoprazole—Omeprazole—ABCG2—hematologic cancer	0.00017	0.0466	CrCbGaD
Pantoprazole—ABCG2—testis—hematologic cancer	0.000169	0.0245	CbGeAlD
Pantoprazole—Lansoprazole—ABCG2—hematologic cancer	0.000155	0.0426	CrCbGaD
Pantoprazole—ABCB1—hematopoietic system—hematologic cancer	0.000152	0.0221	CbGeAlD
Pantoprazole—CYP3A4—blood—hematologic cancer	0.000142	0.0206	CbGeAlD
Pantoprazole—ABCG2—lymph node—hematologic cancer	0.000122	0.0178	CbGeAlD
Pantoprazole—ABCB1—gonad—hematologic cancer	0.000115	0.0168	CbGeAlD
Pantoprazole—ABCB1—blood—hematologic cancer	0.000101	0.0146	CbGeAlD
Pantoprazole—ABCB1—bone marrow—hematologic cancer	9.73e-05	0.0141	CbGeAlD
Pantoprazole—ABCB1—lung—hematologic cancer	8.82e-05	0.0128	CbGeAlD
Pantoprazole—ABCB1—testis—hematologic cancer	8.32e-05	0.0121	CbGeAlD
Pantoprazole—Omeprazole—ABCB1—hematologic cancer	7.07e-05	0.0194	CrCbGaD
Pantoprazole—Lansoprazole—ABCB1—hematologic cancer	6.47e-05	0.0177	CrCbGaD
Pantoprazole—ABCB1—lymph node—hematologic cancer	6.03e-05	0.00876	CbGeAlD
Pantoprazole—Feeling abnormal—Betamethasone—hematologic cancer	8.62e-06	4.98e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Dexamethasone—hematologic cancer	8.62e-06	4.98e-05	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—hematologic cancer	8.61e-06	4.98e-05	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—hematologic cancer	8.61e-06	4.97e-05	CcSEcCtD
Pantoprazole—Tension—Epirubicin—hematologic cancer	8.57e-06	4.95e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.56e-06	4.94e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Betamethasone—hematologic cancer	8.56e-06	4.94e-05	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—hematologic cancer	8.55e-06	4.94e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Triamcinolone—hematologic cancer	8.5e-06	4.91e-05	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—hematologic cancer	8.48e-06	4.9e-05	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—hematologic cancer	8.45e-06	4.88e-05	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—hematologic cancer	8.42e-06	4.86e-05	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—hematologic cancer	8.41e-06	4.86e-05	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—hematologic cancer	8.4e-06	4.85e-05	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—hematologic cancer	8.38e-06	4.84e-05	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—hematologic cancer	8.38e-06	4.84e-05	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—hematologic cancer	8.35e-06	4.83e-05	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—hematologic cancer	8.33e-06	4.81e-05	CcSEcCtD
Pantoprazole—Urticaria—Dexamethasone—hematologic cancer	8.31e-06	4.8e-05	CcSEcCtD
Pantoprazole—Urticaria—Betamethasone—hematologic cancer	8.31e-06	4.8e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.3e-06	4.8e-05	CcSEcCtD
Pantoprazole—Dizziness—Prednisolone—hematologic cancer	8.29e-06	4.79e-05	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—hematologic cancer	8.29e-06	4.79e-05	CcSEcCtD
Pantoprazole—Asthenia—Triamcinolone—hematologic cancer	8.27e-06	4.78e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Dexamethasone—hematologic cancer	8.27e-06	4.78e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Dexamethasone—hematologic cancer	8.27e-06	4.78e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Betamethasone—hematologic cancer	8.27e-06	4.78e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Betamethasone—hematologic cancer	8.27e-06	4.78e-05	CcSEcCtD
Pantoprazole—Nausea—Cisplatin—hematologic cancer	8.24e-06	4.76e-05	CcSEcCtD
Pantoprazole—Insomnia—Prednisone—hematologic cancer	8.24e-06	4.76e-05	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—hematologic cancer	8.23e-06	4.76e-05	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—hematologic cancer	8.2e-06	4.74e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Prednisone—hematologic cancer	8.18e-06	4.73e-05	CcSEcCtD
Pantoprazole—Pruritus—Triamcinolone—hematologic cancer	8.16e-06	4.71e-05	CcSEcCtD
Pantoprazole—Cough—Methotrexate—hematologic cancer	8.14e-06	4.7e-05	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—hematologic cancer	8.13e-06	4.7e-05	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—hematologic cancer	8.1e-06	4.68e-05	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—hematologic cancer	8.09e-06	4.67e-05	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—hematologic cancer	8.08e-06	4.67e-05	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—hematologic cancer	8.08e-06	4.67e-05	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—hematologic cancer	8.07e-06	4.66e-05	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—hematologic cancer	8.03e-06	4.64e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Prednisone—hematologic cancer	8.02e-06	4.63e-05	CcSEcCtD
Pantoprazole—Rash—Etoposide—hematologic cancer	8.02e-06	4.63e-05	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—hematologic cancer	8.01e-06	4.63e-05	CcSEcCtD
Pantoprazole—Headache—Etoposide—hematologic cancer	7.97e-06	4.6e-05	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—hematologic cancer	7.96e-06	4.6e-05	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—hematologic cancer	7.94e-06	4.59e-05	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—hematologic cancer	7.94e-06	4.59e-05	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—hematologic cancer	7.94e-06	4.59e-05	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—hematologic cancer	7.93e-06	4.58e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Prednisone—hematologic cancer	7.92e-06	4.58e-05	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—hematologic cancer	7.91e-06	4.57e-05	CcSEcCtD
Pantoprazole—Rash—Prednisolone—hematologic cancer	7.91e-06	4.57e-05	CcSEcCtD
Pantoprazole—Dermatitis—Prednisolone—hematologic cancer	7.9e-06	4.56e-05	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.89e-06	4.56e-05	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—hematologic cancer	7.88e-06	4.55e-05	CcSEcCtD
Pantoprazole—Fatigue—Prednisone—hematologic cancer	7.86e-06	4.54e-05	CcSEcCtD
Pantoprazole—Headache—Prednisolone—hematologic cancer	7.86e-06	4.54e-05	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—hematologic cancer	7.85e-06	4.54e-05	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—hematologic cancer	7.85e-06	4.53e-05	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—hematologic cancer	7.85e-06	4.53e-05	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—hematologic cancer	7.83e-06	4.52e-05	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—hematologic cancer	7.82e-06	4.52e-05	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—hematologic cancer	7.82e-06	4.52e-05	CcSEcCtD
Pantoprazole—Constipation—Prednisone—hematologic cancer	7.79e-06	4.5e-05	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—hematologic cancer	7.77e-06	4.49e-05	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—hematologic cancer	7.72e-06	4.46e-05	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—hematologic cancer	7.68e-06	4.44e-05	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—hematologic cancer	7.68e-06	4.43e-05	CcSEcCtD
Pantoprazole—Dizziness—Triamcinolone—hematologic cancer	7.63e-06	4.41e-05	CcSEcCtD
Pantoprazole—Cough—Epirubicin—hematologic cancer	7.62e-06	4.4e-05	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—hematologic cancer	7.62e-06	4.4e-05	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—hematologic cancer	7.62e-06	4.4e-05	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—hematologic cancer	7.57e-06	4.37e-05	CcSEcCtD
Pantoprazole—Infection—Methotrexate—hematologic cancer	7.57e-06	4.37e-05	CcSEcCtD
Pantoprazole—Nausea—Etoposide—hematologic cancer	7.55e-06	4.36e-05	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—hematologic cancer	7.54e-06	4.36e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Prednisone—hematologic cancer	7.51e-06	4.34e-05	CcSEcCtD
Pantoprazole—Asthenia—Betamethasone—hematologic cancer	7.51e-06	4.34e-05	CcSEcCtD
Pantoprazole—Asthenia—Dexamethasone—hematologic cancer	7.51e-06	4.34e-05	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—hematologic cancer	7.5e-06	4.33e-05	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—hematologic cancer	7.47e-06	4.32e-05	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—hematologic cancer	7.47e-06	4.32e-05	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—hematologic cancer	7.46e-06	4.31e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Prednisone—hematologic cancer	7.45e-06	4.31e-05	CcSEcCtD
Pantoprazole—Nausea—Prednisolone—hematologic cancer	7.45e-06	4.3e-05	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—hematologic cancer	7.43e-06	4.3e-05	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—hematologic cancer	7.43e-06	4.3e-05	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—hematologic cancer	7.43e-06	4.3e-05	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—hematologic cancer	7.43e-06	4.29e-05	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—hematologic cancer	7.41e-06	4.28e-05	CcSEcCtD
Pantoprazole—Pruritus—Dexamethasone—hematologic cancer	7.4e-06	4.28e-05	CcSEcCtD
Pantoprazole—Pruritus—Betamethasone—hematologic cancer	7.4e-06	4.28e-05	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—hematologic cancer	7.4e-06	4.27e-05	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.38e-06	4.27e-05	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—hematologic cancer	7.36e-06	4.25e-05	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—hematologic cancer	7.35e-06	4.24e-05	CcSEcCtD
Pantoprazole—Vomiting—Triamcinolone—hematologic cancer	7.33e-06	4.24e-05	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—hematologic cancer	7.29e-06	4.21e-05	CcSEcCtD
Pantoprazole—Rash—Triamcinolone—hematologic cancer	7.27e-06	4.2e-05	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—hematologic cancer	7.27e-06	4.2e-05	CcSEcCtD
Pantoprazole—Dermatitis—Triamcinolone—hematologic cancer	7.26e-06	4.2e-05	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—hematologic cancer	7.26e-06	4.19e-05	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—hematologic cancer	7.26e-06	4.19e-05	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—hematologic cancer	7.25e-06	4.19e-05	CcSEcCtD
Pantoprazole—Urticaria—Prednisone—hematologic cancer	7.24e-06	4.18e-05	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—hematologic cancer	7.23e-06	4.18e-05	CcSEcCtD
Pantoprazole—Headache—Triamcinolone—hematologic cancer	7.22e-06	4.17e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Prednisone—hematologic cancer	7.2e-06	4.16e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Prednisone—hematologic cancer	7.2e-06	4.16e-05	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—hematologic cancer	7.19e-06	4.15e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Dexamethasone—hematologic cancer	7.16e-06	4.14e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Betamethasone—hematologic cancer	7.16e-06	4.14e-05	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—hematologic cancer	7.14e-06	4.13e-05	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—hematologic cancer	7.13e-06	4.12e-05	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—hematologic cancer	7.13e-06	4.12e-05	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—hematologic cancer	7.12e-06	4.11e-05	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—hematologic cancer	7.1e-06	4.1e-05	CcSEcCtD
Pantoprazole—Infection—Epirubicin—hematologic cancer	7.08e-06	4.09e-05	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—hematologic cancer	7.05e-06	4.07e-05	CcSEcCtD
Pantoprazole—Shock—Epirubicin—hematologic cancer	7.01e-06	4.05e-05	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—hematologic cancer	7e-06	4.05e-05	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—hematologic cancer	6.99e-06	4.04e-05	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—hematologic cancer	6.98e-06	4.03e-05	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—hematologic cancer	6.98e-06	4.03e-05	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—hematologic cancer	6.96e-06	4.02e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.94e-06	4.01e-05	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—hematologic cancer	6.92e-06	4e-05	CcSEcCtD
Pantoprazole—Dizziness—Betamethasone—hematologic cancer	6.92e-06	4e-05	CcSEcCtD
Pantoprazole—Dizziness—Dexamethasone—hematologic cancer	6.92e-06	4e-05	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—hematologic cancer	6.89e-06	3.98e-05	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—hematologic cancer	6.89e-06	3.98e-05	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—hematologic cancer	6.88e-06	3.97e-05	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—hematologic cancer	6.88e-06	3.97e-05	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—hematologic cancer	6.88e-06	3.97e-05	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—hematologic cancer	6.86e-06	3.96e-05	CcSEcCtD
Pantoprazole—Nausea—Triamcinolone—hematologic cancer	6.85e-06	3.96e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—hematologic cancer	6.84e-06	3.95e-05	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.83e-06	3.95e-05	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—hematologic cancer	6.8e-06	3.93e-05	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—hematologic cancer	6.79e-06	3.93e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—hematologic cancer	6.79e-06	3.92e-05	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—hematologic cancer	6.77e-06	3.91e-05	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—hematologic cancer	6.73e-06	3.89e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Prednisone—hematologic cancer	6.71e-06	3.88e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—hematologic cancer	6.7e-06	3.87e-05	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—hematologic cancer	6.66e-06	3.85e-05	CcSEcCtD
Pantoprazole—Vomiting—Betamethasone—hematologic cancer	6.65e-06	3.84e-05	CcSEcCtD
Pantoprazole—Vomiting—Dexamethasone—hematologic cancer	6.65e-06	3.84e-05	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—hematologic cancer	6.65e-06	3.84e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—hematologic cancer	6.62e-06	3.83e-05	CcSEcCtD
Pantoprazole—Rash—Betamethasone—hematologic cancer	6.6e-06	3.81e-05	CcSEcCtD
Pantoprazole—Rash—Dexamethasone—hematologic cancer	6.6e-06	3.81e-05	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—hematologic cancer	6.59e-06	3.81e-05	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—hematologic cancer	6.59e-06	3.81e-05	CcSEcCtD
Pantoprazole—Dermatitis—Betamethasone—hematologic cancer	6.59e-06	3.81e-05	CcSEcCtD
Pantoprazole—Dermatitis—Dexamethasone—hematologic cancer	6.59e-06	3.81e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.58e-06	3.8e-05	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—hematologic cancer	6.57e-06	3.79e-05	CcSEcCtD
Pantoprazole—Headache—Dexamethasone—hematologic cancer	6.56e-06	3.79e-05	CcSEcCtD
Pantoprazole—Headache—Betamethasone—hematologic cancer	6.56e-06	3.79e-05	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—hematologic cancer	6.55e-06	3.79e-05	CcSEcCtD
Pantoprazole—Asthenia—Prednisone—hematologic cancer	6.54e-06	3.78e-05	CcSEcCtD
Pantoprazole—Pain—Methotrexate—hematologic cancer	6.51e-06	3.76e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.49e-06	3.75e-05	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—hematologic cancer	6.49e-06	3.75e-05	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—hematologic cancer	6.47e-06	3.74e-05	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—hematologic cancer	6.46e-06	3.73e-05	CcSEcCtD
Pantoprazole—Pruritus—Prednisone—hematologic cancer	6.45e-06	3.73e-05	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—hematologic cancer	6.45e-06	3.72e-05	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—hematologic cancer	6.44e-06	3.72e-05	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—hematologic cancer	6.41e-06	3.7e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—hematologic cancer	6.4e-06	3.7e-05	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—hematologic cancer	6.38e-06	3.68e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—hematologic cancer	6.35e-06	3.67e-05	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—hematologic cancer	6.34e-06	3.66e-05	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—hematologic cancer	6.29e-06	3.63e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—hematologic cancer	6.28e-06	3.63e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—hematologic cancer	6.27e-06	3.62e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Prednisone—hematologic cancer	6.24e-06	3.6e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—hematologic cancer	6.23e-06	3.6e-05	CcSEcCtD
Pantoprazole—Nausea—Betamethasone—hematologic cancer	6.22e-06	3.59e-05	CcSEcCtD
Pantoprazole—Nausea—Dexamethasone—hematologic cancer	6.22e-06	3.59e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—hematologic cancer	6.2e-06	3.58e-05	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—hematologic cancer	6.16e-06	3.56e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.15e-06	3.56e-05	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—hematologic cancer	6.14e-06	3.55e-05	CcSEcCtD
Pantoprazole—Pain—Epirubicin—hematologic cancer	6.09e-06	3.52e-05	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—hematologic cancer	6.09e-06	3.52e-05	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—hematologic cancer	6.05e-06	3.5e-05	CcSEcCtD
Pantoprazole—Dizziness—Prednisone—hematologic cancer	6.03e-06	3.48e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—hematologic cancer	6.02e-06	3.48e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—hematologic cancer	6.02e-06	3.48e-05	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.01e-06	3.47e-05	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—hematologic cancer	5.96e-06	3.45e-05	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—hematologic cancer	5.92e-06	3.42e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—hematologic cancer	5.88e-06	3.4e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—hematologic cancer	5.87e-06	3.39e-05	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—hematologic cancer	5.86e-06	3.39e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—hematologic cancer	5.83e-06	3.37e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—hematologic cancer	5.8e-06	3.35e-05	CcSEcCtD
Pantoprazole—Vomiting—Prednisone—hematologic cancer	5.79e-06	3.35e-05	CcSEcCtD
Pantoprazole—Rash—Prednisone—hematologic cancer	5.75e-06	3.32e-05	CcSEcCtD
Pantoprazole—Dermatitis—Prednisone—hematologic cancer	5.74e-06	3.32e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—hematologic cancer	5.73e-06	3.31e-05	CcSEcCtD
Pantoprazole—Headache—Prednisone—hematologic cancer	5.71e-06	3.3e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.69e-06	3.29e-05	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—hematologic cancer	5.69e-06	3.29e-05	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—hematologic cancer	5.66e-06	3.27e-05	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—hematologic cancer	5.64e-06	3.26e-05	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—hematologic cancer	5.64e-06	3.26e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—hematologic cancer	5.63e-06	3.26e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—hematologic cancer	5.63e-06	3.26e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—hematologic cancer	5.61e-06	3.24e-05	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—hematologic cancer	5.46e-06	3.16e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—hematologic cancer	5.43e-06	3.14e-05	CcSEcCtD
Pantoprazole—Nausea—Prednisone—hematologic cancer	5.41e-06	3.13e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.39e-06	3.12e-05	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—hematologic cancer	5.39e-06	3.11e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—hematologic cancer	5.25e-06	3.03e-05	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—hematologic cancer	5.24e-06	3.03e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—hematologic cancer	5.21e-06	3.01e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—hematologic cancer	5.21e-06	3.01e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—hematologic cancer	5.21e-06	3.01e-05	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—hematologic cancer	5.11e-06	2.95e-05	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—hematologic cancer	5.04e-06	2.91e-05	CcSEcCtD
Pantoprazole—Dizziness—Methotrexate—hematologic cancer	5.04e-06	2.91e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—hematologic cancer	4.88e-06	2.82e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—hematologic cancer	4.86e-06	2.81e-05	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—hematologic cancer	4.84e-06	2.8e-05	CcSEcCtD
Pantoprazole—Rash—Methotrexate—hematologic cancer	4.8e-06	2.77e-05	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—hematologic cancer	4.8e-06	2.77e-05	CcSEcCtD
Pantoprazole—Headache—Methotrexate—hematologic cancer	4.77e-06	2.76e-05	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—hematologic cancer	4.73e-06	2.73e-05	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—hematologic cancer	4.71e-06	2.72e-05	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—hematologic cancer	4.67e-06	2.7e-05	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—hematologic cancer	4.53e-06	2.62e-05	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—hematologic cancer	4.52e-06	2.61e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—hematologic cancer	4.51e-06	2.61e-05	CcSEcCtD
Pantoprazole—Rash—Epirubicin—hematologic cancer	4.49e-06	2.6e-05	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—hematologic cancer	4.49e-06	2.59e-05	CcSEcCtD
Pantoprazole—Headache—Epirubicin—hematologic cancer	4.46e-06	2.58e-05	CcSEcCtD
Pantoprazole—CYP2C19—Metabolism—UGT1A1—hematologic cancer	4.38e-06	0.000102	CbGpPWpGaD
Pantoprazole—Dizziness—Doxorubicin—hematologic cancer	4.36e-06	2.52e-05	CcSEcCtD
Pantoprazole—CYP3A4—Metabolism—GBA—hematologic cancer	4.35e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.35e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—IDH1—hematologic cancer	4.3e-06	9.96e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ABCB1—hematologic cancer	4.28e-06	9.92e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.28e-06	9.91e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—IDH2—hematologic cancer	4.27e-06	9.9e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMMR—hematologic cancer	4.27e-06	9.9e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC22A1—hematologic cancer	4.26e-06	9.88e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CRABP1—hematologic cancer	4.26e-06	9.88e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCC3—hematologic cancer	4.25e-06	9.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTO1—hematologic cancer	4.25e-06	9.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TXN—hematologic cancer	4.25e-06	9.85e-05	CbGpPWpGaD
Pantoprazole—Nausea—Epirubicin—hematologic cancer	4.23e-06	2.45e-05	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—hematologic cancer	4.19e-06	2.42e-05	CcSEcCtD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.19e-06	9.71e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.16e-06	9.64e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CRABP1—hematologic cancer	4.16e-06	9.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.16e-06	9.64e-05	CbGpPWpGaD
Pantoprazole—Rash—Doxorubicin—hematologic cancer	4.16e-06	2.4e-05	CcSEcCtD
Pantoprazole—ABCG2—Metabolism—NCOR1—hematologic cancer	4.16e-06	9.63e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTM1—hematologic cancer	4.16e-06	9.63e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALOX5—hematologic cancer	4.16e-06	9.63e-05	CbGpPWpGaD
Pantoprazole—Dermatitis—Doxorubicin—hematologic cancer	4.15e-06	2.4e-05	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—hematologic cancer	4.13e-06	2.39e-05	CcSEcCtD
Pantoprazole—ABCB1—Metabolism—ALOX5—hematologic cancer	4.06e-06	9.4e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.06e-06	9.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.03e-06	9.33e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NUP98—hematologic cancer	4.02e-06	9.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ARNTL—hematologic cancer	4.02e-06	9.31e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4e-06	9.26e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTAP—hematologic cancer	3.98e-06	9.22e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—MTHFR—hematologic cancer	3.97e-06	9.19e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NUP98—hematologic cancer	3.93e-06	9.1e-05	CbGpPWpGaD
Pantoprazole—Nausea—Doxorubicin—hematologic cancer	3.92e-06	2.26e-05	CcSEcCtD
Pantoprazole—CYP1A2—Metabolism—ACP5—hematologic cancer	3.91e-06	9.05e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CA9—hematologic cancer	3.91e-06	9.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ADCY7—hematologic cancer	3.91e-06	9.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NCOA3—hematologic cancer	3.91e-06	9.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC22A1—hematologic cancer	3.89e-06	9.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CRABP1—hematologic cancer	3.89e-06	9.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NUP214—hematologic cancer	3.88e-06	8.99e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOR2—hematologic cancer	3.86e-06	8.93e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.84e-06	8.89e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ADCY7—hematologic cancer	3.81e-06	8.83e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NCOA3—hematologic cancer	3.81e-06	8.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCG2—hematologic cancer	3.8e-06	8.8e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—MTR—hematologic cancer	3.8e-06	8.8e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.79e-06	8.78e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NUP214—hematologic cancer	3.79e-06	8.77e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ENO2—hematologic cancer	3.73e-06	8.63e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—MTR—hematologic cancer	3.71e-06	8.59e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ABCG2—hematologic cancer	3.71e-06	8.59e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—IDH1—hematologic cancer	3.67e-06	8.51e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—MTHFR—hematologic cancer	3.67e-06	8.51e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NUP98—hematologic cancer	3.67e-06	8.5e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ENO2—hematologic cancer	3.64e-06	8.43e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCC3—hematologic cancer	3.63e-06	8.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TXN—hematologic cancer	3.63e-06	8.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTO1—hematologic cancer	3.63e-06	8.42e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.62e-06	8.37e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.56e-06	8.25e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.56e-06	8.25e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.56e-06	8.25e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.56e-06	8.24e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—FHL2—hematologic cancer	3.55e-06	8.22e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NUP214—hematologic cancer	3.54e-06	8.19e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SDC1—hematologic cancer	3.53e-06	8.18e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTT1—hematologic cancer	3.53e-06	8.17e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.5e-06	8.11e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.5e-06	8.1e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AGRN—hematologic cancer	3.48e-06	8.06e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.47e-06	8.03e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—MTR—hematologic cancer	3.47e-06	8.03e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SDC1—hematologic cancer	3.45e-06	7.99e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.42e-06	7.93e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3.42e-06	7.91e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ENO2—hematologic cancer	3.4e-06	7.87e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.38e-06	7.82e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	3.33e-06	7.72e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.33e-06	7.72e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.32e-06	7.7e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.32e-06	7.7e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.3e-06	7.65e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—IDH2—hematologic cancer	3.3e-06	7.64e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMMR—hematologic cancer	3.3e-06	7.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.3e-06	7.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.25e-06	7.52e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.24e-06	7.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SDC1—hematologic cancer	3.22e-06	7.46e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.19e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NUP98—hematologic cancer	3.14e-06	7.26e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.1e-06	7.18e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.09e-06	7.16e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CREBBP—hematologic cancer	3.09e-06	7.16e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.09e-06	7.15e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.08e-06	7.13e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.04e-06	7.05e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.04e-06	7.05e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.04e-06	7.04e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NUP214—hematologic cancer	3.02e-06	7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ACP5—hematologic cancer	3.02e-06	6.99e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CA9—hematologic cancer	3.02e-06	6.99e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NQO1—hematologic cancer	3e-06	6.96e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CD44—hematologic cancer	3e-06	6.96e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.99e-06	6.93e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.98e-06	6.89e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTR—hematologic cancer	2.96e-06	6.86e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.96e-06	6.86e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.94e-06	6.81e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CD44—hematologic cancer	2.93e-06	6.79e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NQO1—hematologic cancer	2.93e-06	6.79e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.93e-06	6.79e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.91e-06	6.73e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ENO2—hematologic cancer	2.9e-06	6.73e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—hematologic cancer	2.89e-06	6.7e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CREBBP—hematologic cancer	2.86e-06	6.63e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYCS—hematologic cancer	2.84e-06	6.59e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—IDH1—hematologic cancer	2.84e-06	6.57e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.82e-06	6.54e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.82e-06	6.52e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.8e-06	6.49e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.8e-06	6.49e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TXN—hematologic cancer	2.8e-06	6.49e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYCS—hematologic cancer	2.77e-06	6.43e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.77e-06	6.42e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.77e-06	6.41e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.76e-06	6.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SDC1—hematologic cancer	2.75e-06	6.38e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.74e-06	6.36e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NQO1—hematologic cancer	2.74e-06	6.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CD44—hematologic cancer	2.74e-06	6.35e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.71e-06	6.29e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.68e-06	6.21e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—hematologic cancer	2.68e-06	6.21e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.64e-06	6.11e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.63e-06	6.09e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.6e-06	6.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYCS—hematologic cancer	2.59e-06	6e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.58e-06	5.97e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.56e-06	5.94e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.56e-06	5.94e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.56e-06	5.94e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.55e-06	5.92e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.54e-06	5.89e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.51e-06	5.8e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.5e-06	5.79e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.48e-06	5.75e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—hematologic cancer	2.45e-06	5.67e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.42e-06	5.62e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NUP98—hematologic cancer	2.42e-06	5.61e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.37e-06	5.49e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.37e-06	5.48e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.35e-06	5.44e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.35e-06	5.44e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CD44—hematologic cancer	2.34e-06	5.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NQO1—hematologic cancer	2.34e-06	5.42e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NUP214—hematologic cancer	2.33e-06	5.4e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.32e-06	5.37e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.3e-06	5.33e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.3e-06	5.33e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.29e-06	5.31e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTR—hematologic cancer	2.29e-06	5.29e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.29e-06	5.29e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.28e-06	5.29e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NCOR1—hematologic cancer	2.25e-06	5.21e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—hematologic cancer	2.25e-06	5.21e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ENO2—hematologic cancer	2.24e-06	5.19e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYCS—hematologic cancer	2.22e-06	5.13e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.21e-06	5.12e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.21e-06	5.11e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.2e-06	5.1e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.17e-06	5.04e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.16e-06	5.01e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SDC1—hematologic cancer	2.12e-06	4.92e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—EP300—hematologic cancer	2.11e-06	4.88e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.1e-06	4.86e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.1e-06	4.86e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—hematologic cancer	2.04e-06	4.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.04e-06	4.71e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—MTHFR—hematologic cancer	1.99e-06	4.6e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.98e-06	4.59e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.95e-06	4.52e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—EP300—hematologic cancer	1.95e-06	4.52e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.89e-06	4.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.86e-06	4.3e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.85e-06	4.28e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NQO1—hematologic cancer	1.81e-06	4.19e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CD44—hematologic cancer	1.81e-06	4.19e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.79e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.79e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.79e-06	4.15e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.71e-06	3.96e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYCS—hematologic cancer	1.71e-06	3.96e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.7e-06	3.93e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.67e-06	3.87e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.64e-06	3.79e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.59e-06	3.67e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.59e-06	3.67e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.56e-06	3.61e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.56e-06	3.61e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CREBBP—hematologic cancer	1.55e-06	3.58e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.51e-06	3.49e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.5e-06	3.48e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—hematologic cancer	1.48e-06	3.44e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.47e-06	3.4e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—hematologic cancer	1.45e-06	3.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.45e-06	3.35e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.44e-06	3.34e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.43e-06	3.3e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.42e-06	3.29e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.4e-06	3.24e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.39e-06	3.21e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.38e-06	3.21e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.38e-06	3.21e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.37e-06	3.17e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—hematologic cancer	1.35e-06	3.13e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.33e-06	3.09e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.31e-06	3.03e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.29e-06	3e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.28e-06	2.96e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.27e-06	2.95e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.24e-06	2.86e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.22e-06	2.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.19e-06	2.77e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—hematologic cancer	1.18e-06	2.73e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.17e-06	2.71e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—hematologic cancer	1.16e-06	2.68e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—hematologic cancer	1.13e-06	2.62e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.11e-06	2.56e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—hematologic cancer	1.11e-06	2.56e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—EP300—hematologic cancer	1.08e-06	2.5e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—EP300—hematologic cancer	1.05e-06	2.44e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—hematologic cancer	1.03e-06	2.39e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.03e-06	2.38e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.02e-06	2.36e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—EP300—hematologic cancer	9.84e-07	2.28e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.53e-07	2.21e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.04e-07	2.09e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—hematologic cancer	8.92e-07	2.07e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—hematologic cancer	8.82e-07	2.04e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.54e-07	1.98e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—EP300—hematologic cancer	8.41e-07	1.95e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.99e-07	1.85e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.88e-07	1.83e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.8e-07	1.81e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.28e-07	1.69e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—hematologic cancer	6.81e-07	1.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—hematologic cancer	6.52e-07	1.51e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—EP300—hematologic cancer	6.49e-07	1.5e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—hematologic cancer	6.37e-07	1.48e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.22e-07	1.44e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—hematologic cancer	5.95e-07	1.38e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—hematologic cancer	5.08e-07	1.18e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.8e-07	1.11e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—hematologic cancer	3.92e-07	9.09e-06	CbGpPWpGaD
